Brind.

OCS technology is cited as a key factor driving the growth of Transmedics.

4 reports, 2 independent Updated Aug 30
Gone quiet Reached 2 outlets in its first 24 hours
Reports
4
Developments
2
Repetition
75%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

OCS technology is cited as a key factor driving the growth of Transmedics.

Who's involved

What this event is mainly about
OCSTransmedics

How it developed

Newest first. Tap a step to see who reported it.
  1. OCS technology was cited for keeping donated organs healthy and providing better outcomes for transplant recipients.Sub-event
  2. OCS technology drives Transmedics growth.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • ZacksReasons to Retain TransMedics Stock in Your Portfolio for Now TransMedics Group, Inc. TMDX is well-poised for growth in the coming quarters, courtesy of its strength in OCS technology. The optimism,
  • ZacksWhy Is TransMedics (TMDX) Down 1.9% Since Last Earnings Report? It has been about a month since the last earnings report for TransMedics (TMDX). Shares have lost about 1.9% in that time frame, underp
  • ZacksTMDX Stock Gains Post Q2 Earnings & Revenue Beat, Margins Up TransMedics Group, Inc. TMDX delivered earnings per share (EPS) of 92 cents in the second quarter of 2025, which surged 162.9% year over y
  • PR NewswireTransMedics Reports Second Quarter 2025 Financial Results ANDOVER, Mass., July 30, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is tr